Verapamil, and Its Metabolite Norverapamil, Inhibit Macrophage-induced, Bacterial Efflux Pump-mediated Tolerance to Multiple Anti-tubercular Drugs
Author:
Affiliation:
1. Department of Microbiology
2. Department of Medicine, Division of Infectious Diseases
3. Department of Immunology, University of Washington, Seattle, Washington
Funder
NIH
the recipient of the Merle A. Sande-Pfizer Fellowship in International Infectious Diseases
NIH Director's Pioneer Award
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Immunology and Allergy
Link
http://academic.oup.com/jid/article-pdf/210/3/456/13804954/jiu095.pdf
Reference50 articles.
1. Controlled clinical trial of short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis;Lancet,1972
2. Shortening treatment in adults with noncavitary tuberculosis and 2-month culture conversion;Johnson;Am J Respir Crit Care Med,2009
3. Why is long-term therapy required to cure tuberculosis?;Connolly;PLoS Med,2007
4. M. tuberculosis persistence, latency, and drug tolerance;Gomez;Tuberculosis,2004
5. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies;Barry;Nat Rev Microbiol,2009
Cited by 126 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Boosting Gentamicin Activity Against Pseudomonas aeruginosa Using Nano-formulation of Curcumin;BioNanoScience;2024-07-06
2. Investigation of the role of Cremophor RH 40 and Cremophor EL in the inhibition of efflux pump of Pseudomonas aeruginosa;Heliyon;2024-07
3. Improving the treatment of bacterial infections caused by multidrug-resistant bacteria through drug repositioning;Frontiers in Pharmacology;2024-06-07
4. Three-Dimensional Culture Modelling Reveals Divergent Mycobacterium tuberculosis Virulence and Antimicrobial Treatment Response;Cellular Microbiology;2024-05-03
5. Metabolic Rewiring of Mycobacterium tuberculosis upon Drug Treatment and Antibiotics Resistance;Metabolites;2024-01-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3